arrow
R

Ronald C. Petersen

Mayo Clinic
H指数:205
被引数:19.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A model of brain function to predict tau across Alzheimer’s disease and related disorders

阿尔茨海默病及相关障碍中预测tau蛋白的脑功能模型

2026-10-020
OAAI
Perivascular Spaces as Determinants of Amyloid, Tau, and Vascular Biomarker Progression

血管周围间隙作为决定性淀粉样蛋白、tau蛋白和血管生物标志物进展的因素

2026-07-290
OAAI
Biochemical and Immunohistochemical Associations of TDP-43 and Cryptic RNA With Hippocampal and Amygdala Volumetrics in Alzheimer's Disease

TDP-43和隐藏RNA与阿尔茨海默病中海马体和杏仁核体积测量的生物化学和免疫组化关联

2026-04-080
OAAI
Divergent white matter metabolic signature patterns indicate impending cognitive decline in aging and dementia

不同的白质代谢特征模式表明衰老和痴呆症的认知能力下降

2026-03-190
OAAI
Lifetime and 10-year absolute risk of cognitive impairment in relation to amyloid PET severity: a retrospective, longitudinal cohort study

与淀粉样蛋白PET严重程度相关的认知障碍的终身及10年绝对风险:一项回顾性、纵向队列研究

2025-11-120
PRE
Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease

人类白细胞抗原等位基因与路易体病神经病理学结局的关联

2025-11-070
OAAI
Association between antemortem plasma and structural MRI biomarkers and postmortem tau pathology in the Mayo Clinic Study of Aging

梅奥诊所老龄化研究中,抗-mortem血浆和结构MRI生物标志物与死后tau病理学之间的关系

2025-10-150
OAAI
Predictive Value of Plasma Biomarkers in Tau-PET Transitions

血浆生物标志物在Tau-PET转化中的预测价值

2025-09-100
PRE
Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals

血浆阿尔茨海默病生物标志物与认知功能完好个体认知下降的关联

2025-08-290
OAAI
Methylome analysis of FTLD patients with TDP-43 pathology identifies epigenetic signatures specific to pathological subtypes

FTLD患者TDP-43病理的表观基因组分析鉴定出与病理亚型相关的特异表观遗传特征

2025-08-260
PRE
18F-FDG PET in detection of primary age-related tauopathy (PART) – Is there a role? Insights from an imaging-pathology correlation study

18F-FDG PET在检测原发性年龄相关tau病(PART)中的应用——是否有作用?——来自一项影像-病理相关性研究的见解

2025-08-190
OAAI
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex

tau PET阳性率在伴有和不伴有认知障碍的个体中,随年龄、Aβ状态、APOE基因型和性别而变化。

2025-07-160
OA
Author Correction: Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer’s disease copathologies

作者更正:路易体痴呆的皮层微观结构异常及其与阿尔茨海默病共病病理学的关联

2025-07-120
OA
Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicing

FTLD-TDP前额皮质剪接景观的分析揭示了亚型特异模式及隐匿剪接。

2025-06-060
OAAI
Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer’s disease copathologies

Mak, E.; Reid, R.I.; Przybelski, S.A.; Fought, A.J.; Lesnick, T.G.; Schwarz, C.G.; Senjem, M.L.; Raghavan, S.; Vemuri, P.; Jack, C.R.; 等. 路易体痴呆中的皮层微结构异常及其与阿尔茨海默病共病病理的关系。npj Parkinsons Dis. 2025, 11, 124. [Google Scholar] [CrossRef] [PubMed]

2025-05-120
OA
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing

通过全基因组测序破译ftld-tdp病理亚型的不同遗传危险因素

2025-04-250
OA